T1D Exchange at the 84th Scientific Sessions

Visit us in the exhibit hall throughout the conference to learn more about our upcoming ADEPT health equity conference, presentations, quality improvement initiatives, custom research offerings, study recruitment services, and more! 

T1D Exchange Booth: #646 
ADEPT Health Equity Conference Booth: #855

FRIDAY, JUNE 21  

9:30 – 10:00 a.m. | Room W303

ADA Scholars Session: ADA Standards of Care–Quality Improvement and Population Health

• Does Quality Improvement Impact Outcomes for People Living With Diabetes?
  • Presented by: Osagie Ebekozien, MD, MPH, CPHQ, T1D Exchange 

6:00 – 6:15 p.m. | Room W308 | 5:30 – 6:30 p.m. session 

Oral Presentations – Innovative Diabetes Self-Management Education Across Diverse Populations   

• Examining New-Onset Type 1 Diabetes Educational Practices among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) [136-OR]
  • Presented by: Ryan McDonough, DO, Children’s Mercy – Kansas City 

SATURDAY, JUNE 22 

12:30 – 1:30 p.m. | General Poster Session | Poster Hall (West A4-B2) 

• 367-P Clinical Characteristics of Type 1 Diabetes and Severe Hypoglycemia in Adult Continuous Glucose Monitor Users
  • Presented by: Patrick Callahan, PharmD, MS, Vertex Pharmaceuticals Incorporated 

• 370-P Anxiety and Depressive Symptoms of Type 1 Diabetes and Severe Hypoglycemia in Adult Continuous Glucose Monitor Users
  • Presented by: Adriana Boateng-Kuffour, MS, MPH, Vertex Pharmaceuticals Incorporated 

• 700-P Recent and Lifetime Experiences with Diabetes Distress in Adults with T1D
  • Presented by: Katherine SM Chapman, T1D Exchange  

• 959-P Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) Versus Non-AID Insulin Pump for Newly Diagnosed People With Type 1 Diabetes Offers Improvement in Glycemic Control
  • Presented by: Saketh Rompicherla, MS, T1D Exchange 

• 1293-P Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness Among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
  • Presented by: Carla Demeterco-Berggren, MD, PhD, UCSD/Rady Children’s Hospital, San Diego 

• 1456-P Type 1 Diabetes Care and Device Use in Older Adults: Transatlantic Comparison Based on T1DX-QI and DPV Registries
  • Presented by: Kathryn Fantasia, MD, MSc, Boston Medical Center 

• 1939-LB Improving Capacity for Quality Improvement in Type 2 Diabetes Primary Care Centers
  • Presented by: Nicole Rioles, MA, T1D Exchange 

SUNDAY, JUNE 23 

12:30 – 1:30 p.m. | General Poster Session | Poster Hall (West A4-B2) 

• 778-P Changes in HbA1c with GLP-1 Use in People With Type 1 Diabetes: Data from the T1D Exchange QI Initiative
  • Presented by: Carol J. Levy, MD, CDCES, Icahn School of Medicine at Mount Sinai 

• 804-P Understanding Off-Label Use of GLP (Glucagon-Like Peptide-1 Receptor) Agonists Among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
  • Presented by: Mary Pat Gallagher, MD, Hassenfeld Children’s Hospital at NYU Langone 

• 1109-P Diabetes Technology Education Processes Among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
  • Presented by: Risa M. Wolf, MD, Johns Hopkins University 

• 1118-P Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real World Data and Improvement Projects
  • Presented by: Anton Wirsch, MS, T1D Exchange  

• 1131-P Successful Strategies To Reduce Delays in Quality Data Reporting
  • Presented by: Anton Wirsch, MS, T1D Exchange 

1:30 – 3:00 p.m. | Room W307  

Oral Presentations – Continuous Glucose Monitoring—Can It Reduce Hypoglycemia Burden? 

• 1:45 p.m. Longitudinal Assessment of Glycemia and Severe Hypoglycemia Among Adults with T1D: An Online Survey [240-OR]
  • Presented by: Jennifer L. Sherr, MD, PhD, Yale University School of Medicine 

• 2:00 p.m. Health-Related Quality of Life and Burden of Type 1 Diabetes and Severe Hypoglycemia in Adult Continuous Glucose Monitor Users [241-OR]
  • Presented by: Adriana Boateng-Kuffour, MS, MPH, Vertex Pharmaceuticals Incorporated 

• 2:45 p.m. Association of Type 1 Diabetes Duration or Duration of Advanced Technology Utilization With Severe Hypoglycemic Event Frequency [244-OR]
  • Presented by: Patrick Callahan, PharmD, MS, Vertex Pharmaceuticals Incorporated 

2:30 – 2:45 p.m. | W415C (Valencia Ballroom) | 1:30 – 3:00 p.m. session 

Oral Presentations – Weighing Opportunities of Incretin-Based Therapy in Obesity 

• Understanding Patterns of GLP-1/GLP-1 RA Use Among Individuals With Type 1 Diabetes: A T1D Exchange (T1DX) Online Registry Analysis [265-OR]
  • Presented by: Yogish C Kudva, MD, Mayo Clinic 

3:15 – 3:30 p.m. | Room W315 | 3:15 – 4:15 p.m. session 

Oral Presentations – New Insights and Treatments in Management of Youth With Type 1 Diabetes Mellitus 

• ADA Presidents’ Select Abstract: Dynamics of Treatment Regimens and Glycemic Outcomes in >100,000 Children From International Pediatrics Diabetes Registries [329-OR]
  • Presented by: Anthony Zimmerman, MBBS, FRACP, Lyell McEwin Hospital 

MONDAY, JUNE 24 

8:20 – 8:40 a.m. | Room W311 | 8:00 – 9:30 a.m. session 

Symposium – Cost and Quality—Improving Diabetes Care and the Cost of Ongoing Inequities 

• Improving Diabetes Outcomes and Reducing Inequities Through Collaboration: Perspective From the T1D Exchange
  • Presented by: Osagie Ebekozien, MD, MPH, CPHQ, T1D Exchange 

3:35 – 3:55 p.m. | Room W315 | 3:15 – 4:15 p.m. session 

Symposium – Improving Culture of Quality in Pediatric Centers—Lessons From the Type 1 Diabetes Exchange Quality Improvement Collaborative 

• Current Approaches to Addressing Racial Equity—Insights from the T1D Exchange QI Collaborative
  • Presented by: Trevon Wright, MHA, T1D Exchange